Antropy Health Insights@AntropyHealthRetatrutide, an experimental drug currently in Phase 3 clinical trials, is nicknamed the Godzilla of weight-loss jabs because of its potential superior efficacy
Lifestyle modification remains the cornerstone of weight management
Unlike a safe skin brightening treatment, these products often contain harmful ingredients like mercury or steroids
Track progress with monthly photos
Today, we're taking a pivotal step forward in addressing some of the most pressing health issues of our time with the added indication for Wegovy , said Doug Langa, Executive Vice President, Head of North America Operations, and President of Novo Nordisk Inc
Areas of theoretical concern include: Glycaemic instability , particularly in those on antidiabetic medications Altered lipid metabolism , given GH's effects on fatty acid mobilisation Indirect cardiovascular effects , as elevated heart rate has been observed with glucagon receptor agonism and fluid retention is associated with GH excess [1] [17] There are no formal interaction data linking retatrutide and sermorelin to specific adverse outcomes, but the absence of evidence must not be interpreted as confirmation of safety